AVINZA 120 Pill — BLUE;PURPLE;WHITE CAPSULE, 19mm — Morphine

No photo available

Imprint	AVINZA / 120
Colour	BLUE;PURPLE;WHITE
Shape	CAPSULE
Size	19
Strength	MORPHINE SULFATE 120 mg
Dosage form	Capsule, Extended Release
Manufacturer	Pfizer Laboratories Div Pfizer Inc
NDC	60793-608
Schedule	CII
Availability	—
Ingredients	MORPHINE SULFATE[MORPHINE]

What does this imprint mean?

The imprint "AVINZA 120" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Morphine

Uses and warnings

BOXED WARNING (multiple black-box risks typical of Schedule II opioids): "Addiction, Abuse, and Misuse" - morphine "exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death," requiring assessment of each patient's risk before prescribing and monitoring during use; "Life-Threatening Respiratory Depression" - serious, life-threatening, or fatal respiratory depression may occur, with risk greatest during initiation or dose increases; "Accidental Ingestion" can cause fatal overdose, especially in children; "Neonatal Opioid Withdrawal Syndrome" with prolonged use in pregnancy; and "Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants," which can cause profound sedation, respiratory depression, coma, and death. It is a Schedule II controlled substance with high abuse potential. Contraindications include significant respiratory depression, acute or severe bronchial asthma in an unmonitored setting, known or suspected GI obstruction/paralytic ileus, and hypersensitivity.

Morphine Sulfate Tablets are indicated for "the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate," covering relief of moderate to severe acute and chronic pain.

Read the full drug profile →